B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

2.900 -0.060 (-2.03%)
Streaming Delayed Price Updated: 2:18 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,634
Open 2.910
Bid (Size) 2.900 (100)
Ask (Size) 2.910 (200)
Prev. Close 2.960
Today's Range 2.900 - 3.125
52wk Range 2.760 - 55.20
Shares Outstanding 620,290
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Researchers Trace Differing Pediatric Brain Tumors to Common Source
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology And Oncology Pipeline Expansion
Via Investor Brand Network

Performance

YTD
-45.3%
-45.3%
1 Month
-32.1%
-32.1%
3 Month
-61.5%
-61.5%
6 Month
-58.6%
-58.6%
1 Year
-90.3%
-90.3%

More News

Read More
News headline image
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
Via ACCESS Newswire
New Research Challenges Current Thinking on How Brain Cancer Develops
Via Investor Brand Network
New Treatment Dramatically Improves Survival for Patients with Deadly Brain Tumors
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces CEO Transition
Via ACCESS Newswire
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer
Via Investor Brand Network
New Study Unveils Promising Way to Conduct Brain Surgery Against Cancer
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
Via ACCESS Newswire
American Science Suffers as Brain Drain Intensifies
Via Investor Brand Network
Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
Via ACCESS Newswire
Groundbreaking Study Uncovers Why Breast Cancer Metastasizes to the Brain
Via Investor Brand Network
New AI Model Predicts Dementia Risk, Cancer Survival and Brain Age
Via Investor Brand Network
Topics Artificial Intelligence
New Photodynamic Therapy Offers Hope Against Brain Cancer
Via Investor Brand Network
Researchers Develop Smart Nanoparticles to Destroy Proteins That Cause Diseases
Via Investor Brand Network
New Compound Could Become a Transformational Brain Cancer Pill
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287
Via Investor Brand Network
New Digital Twin Predicts Outcomes of Brain Cancer Treatments
Via Investor Brand Network
Topics Artificial Intelligence
Penn State to Participate in Researching Potential Treatment for Pediatric Brain Cancer
Via Investor Brand Network
Preclinical Study Suggests Combo Therapy Could Treat Glioblastoma
Via Investor Brand Network
Experts’ Views on Screen Time and Lifestyle on Pediatric Brain Tumors
Via Investor Brand Network
New Blood Test Reveals Whether Treatment is Working for Brain Cancer Patients
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 2.900
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 03/12/26 02:18 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 1.80M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.